Journal of Molecular and Genetic medicine is one of the top journals of molecular pharmacology that aims to publish the latest developments in cellular pharmacology with a emphasis on the mechanism of action of novel drugs under development, innovative pharmacological technologies, cell signaling, transduction pathway analysis, genomics, proteomics, and metabonomics applications to drug action.
Journal of Molecular and Genetic medicine intends to impart the enhanced clinical profits for human wellbeing from the trial and translational exploration performed utilizing molecular tools. Areas that are secured incorporate, yet are not restricted to, tumor science, immunology, neuroscience, cardiovascular disease, heredity and genomics, gene therapy and stem cells and regenerative medicine.
OMICS Group Journals are known for their high impact factor journals and a section of OMICS Group journals are indexed in the world renowned science database like Medline, PubMed Central, Obscure and Scopus. OMICS acquired as many as 40 reputed journals such as Oral Health and Dental Management and Molecular, genetic Medicine and others.
Yet another prominent feature of OMICS Group Publication activities is its alliance with reputed scientific research, academic institutions and International associations, societies as well as world federations. This alliance is paving the way for collaboration in the areas of journal production, review process, quality and subscription management.
Last date updated on June, 2014